Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Metabolex gets $75mm with private financing

Executive Summary

Metabolex (drugs to treat diabetes and other metabolic disorders) has raised $75mm with the private placement of shares to lead investors Bay City Capital (return investor), Biotech Turnaround Fund BV (new), and Alta Partners (new) CDP Capital Technology Ventures (new). Existing shareholder Charter Ventures and new investors KBC, Birchmere Ventures, Venrock Associates, Versant Ventures, Novo AS, and Merlin Biomed Group also participated. CIBC World Markets acted as placement agent for the transaction.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies